Company Filing History:
3 out of 1,504 
2 out of 19 
2 out of 815 
Years Active: 2020-2025
Title: The Innovative Contributions of Ruiyang Zou in Breast Cancer Research
Introduction
Ruiyang Zou, an accomplished inventor based in Singapore, has made significant strides in the field of breast cancer research. With a portfolio of four patents, his work focuses on innovative methods of diagnosing and treating breast cancer through advanced technologies.
Latest Patents
One of Ruiyang Zou's notable patents is a method of determining and treating breast cancer in a subject. This technology leverages miRNA panels to differentiate between malignant and benign breast lesions, providing crucial information for patients. Another significant patent details methods for assessing the risk of developing breast cancer by evaluating expression levels of specific microRNAs (miRNAs). This approach involves analyzing miRNA hsa-miR-186-5p and hsa-miR-409-3p in bodily fluid samples, where their respective upregulation or downregulation indicates a patient's status concerning breast cancer.
Career Highlights
Ruiyang Zou has been affiliated with reputable institutions, including the Agency for Science, Technology and Research, and the National University of Singapore. His dedication to cancer research not only showcases his inventive capabilities but also his commitment to advancing medical science.
Collaborations
Throughout his career, Ruiyang has collaborated with esteemed colleagues, including Heng-phon Too and Lihan Zhou. These partnerships have enabled him to share insights and foster innovation in cancer research, ultimately contributing to the development of effective diagnostic and treatment methods.
Conclusion
Ruiyang Zou's innovative patents and research have paved the way for new strategies in the fight against breast cancer. His work exemplifies the importance of scientific collaboration and the impact of ingenuity in addressing significant health challenges. As he continues to explore the potentials of microRNA technology, the medical community eagerly anticipates further contributions that may emerge from his groundbreaking efforts.